Capital Investment Counsel, Inc Amgen Inc Transaction History

Capital Investment Counsel, Inc

$695 Million
Q3 2024

A detailed history of Capital Investment Counsel, Inc transactions in Amgen Inc stock. As of the latest transaction made, Capital Investment Counsel, Inc holds 2,390 shares of AMGN stock, worth $692,861. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,390

Previous 4,665 48.77%

Holding current value

$692,861

Previous $1.46 Million 47.15%

% of portfolio

0.11%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $703,839 - $767,539	-2,275 Reduced 48.77%	2,390 $770,000
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $26,275 - $31,931	-100 Reduced 2.1%	4,665 $1.46 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 0.21%	4,765 $1.37 Million
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $2,405 - $2,986	11 Added 0.23%	4,775 $1.28 Million
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $1,928 - $2,280	9 Added 0.19%	4,764 $1.06 Million
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $67,737 - $82,560	-300 Reduced 5.93%	4,755 $1.15 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $17,177 - $21,825	75 Added 1.51%	5,055 $1.33 Million
Q3 2022 Oct 26, 2022	SELL	$224.46 - $253.15 $38,158 - $43,035	-170 Reduced 3.3%	4,980 $1.12 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 0.58%	5,150 $1.25 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $32,890 - $36,385	150 Added 2.98%	5,180 $1.25 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $523,054 - $598,588	2,630 Added 109.58%	5,030 $1.13 Million
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $84,908 - $99,480	400 Added 20.0%	2,400 $510,000
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $116,790 - $129,570	500 Added 33.33%	2,000 $488,000
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $66,573 - $77,580	300 Added 25.0%	1,500 $373,000
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $7,039 - $7,828	-30 Reduced 2.44%	1,200 $305,000
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 7.52%	1,230 $297,000
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $18,529 - $20,889	-100 Reduced 6.99%	1,330 $276,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $37,361 - $41,964	-225 Reduced 13.6%	1,430 $264,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $16,943 - $19,800	100 Added 6.43%	1,655 $282,000
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $16,879 - $18,859	-100 Reduced 6.04%	1,555 $270,000
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $276,864 - $316,105	1,655	1,655 $309,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, Inc with notifications on news.

Account

Capital Investment Counsel, Inc Amgen Inc Transaction History